STABLIX Trademark

Trademark Overview


On Friday, June 4, 2021, a trademark application was filed for STABLIX with the United States Patent and Trademark Office. The USPTO has given the STABLIX trademark a serial number of 90755882. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 14, 2025. This trademark is owned by Stablix, Inc.. The STABLIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the restoration of protein stability and function; Pharmaceutical preparations comprising small molecules for stabilizing cellular proteins to restore normal function and treat disease; pharmaceutical preparations for targeted protein stabilization

Pharmaceutical products development of new small molecules aimed at stabilizing cellular proteins to restore normal function and treat disease; research and development of therapeutic modalities for treatment of diseases; research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; research and development services in the field of protein stabilization therapeutics
stablix

General Information


Serial Number90755882
Word MarkSTABLIX
Filing DateFriday, June 4, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the restoration of protein stability and function; Pharmaceutical preparations comprising small molecules for stabilizing cellular proteins to restore normal function and treat disease; pharmaceutical preparations for targeted protein stabilization
Goods and ServicesPharmaceutical products development of new small molecules aimed at stabilizing cellular proteins to restore normal function and treat disease; research and development of therapeutic modalities for treatment of diseases; research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; research and development services in the field of protein stabilization therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameStablix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Party NameStablix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10032

Trademark Events


Event DateEvent Description
Friday, March 4, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 8, 2021NEW APPLICATION ENTERED
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 18, 2022ASSIGNED TO EXAMINER
Friday, March 4, 2022EXAMINERS AMENDMENT E-MAILED
Friday, March 4, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 4, 2022EXAMINER'S AMENDMENT ENTERED
Monday, March 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2022ASSIGNED TO LIE
Wednesday, March 9, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 29, 2022SOU EXTENSION 1 FILED
Tuesday, November 29, 2022SOU EXTENSION 1 GRANTED
Thursday, December 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023SOU EXTENSION 2 FILED
Tuesday, June 6, 2023SOU EXTENSION 2 GRANTED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 14, 2023SOU EXTENSION 3 FILED
Tuesday, November 14, 2023SOU EXTENSION 3 GRANTED
Thursday, November 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2024SOU EXTENSION 4 FILED
Tuesday, April 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 23, 2024SOU EXTENSION 4 GRANTED
Wednesday, April 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 4, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 14, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, July 14, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, February 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2024SOU EXTENSION 5 FILED
Tuesday, February 4, 2025SOU EXTENSION 5 GRANTED